- Package
- 1 g
- Purity
- 99%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 29094-61-9
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
29094-61-9
PubChem CID
3478
Molecular Formula
C21H27N5O4S
Molecular Weight
445.5 g/mol
Exact Mass
445.178376
InChIKey
ZJJXGWJIGJFDTL-UHFFFAOYSA-N
IUPAC Name
N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
SMILES String
CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
Melting Point
208–209 °C
pKa
5.9
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Glipizide (CAS 29094-61-9) is listed in the Advanced Chemicals portfolio, with molecular formula C21H27N5O4S and molecular weight 445. 50 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Nuclear factor NF-kappa-B p105 subunit (Homo sapiens) — 2 assays; Cannabinoid receptor 1 (Homo sapiens) — 4 assays; Cytochrome P450 3A4 (Homo sapiens) — 3 assays; Cytochrome P450 2C9 (Homo sapiens) — 2 assays; Alpha-1A adrenergic receptor (Homo sapiens) — 4 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Nuclear factor NF-kappa-B p105 subunit
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 7.95
Experimental evidence source: ChEMBL
Cannabinoid receptor 1
Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 1 documents · best pChEMBL 7.73
Experimental evidence source: ChEMBL
Cytochrome P450 3A4
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 2 documents · best pChEMBL 5.13
Experimental evidence source: ChEMBL
Cytochrome P450 2C9
Homo sapiens · SINGLE PROTEIN · 2 qualifying assays · 1 documents · best pChEMBL 5.1
Experimental evidence source: ChEMBL
Alpha-1A adrenergic receptor
Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 1 documents · best pChEMBL 4.85
Experimental evidence source: ChEMBL
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Glipizide is identified by CAS 29094-61-9, with molecular formula C21H27N5O4S, molecular weight 445.5, InChIKey ZJJXGWJIGJFDTL-UHFFFAOYSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Nuclear factor NF-kappa-B p105 subunit, Cannabinoid receptor 1, Cytochrome P450 3A4, Cytochrome P450 2C9, Alpha-1A adrenergic receptor. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.